Aker BioMarine AS reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 69.1 million compared to USD 56.9 million a year ago. Net loss was USD 17.6 million compared to USD 9.8 million a year ago.

Basic loss per share from continuing operations was USD 0.2 compared to USD 0.1 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.1 a year ago.